Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 40 for “"auranofin"”.
-
AURANOFIN INHIBITS VIRULENCE IN PSEUDOMONAS AERUGINOSA
… using high-throughput screening and yielded auranofin, which displayed sub-micro molar activity against LasR-mediated expression of lasB. Additionally, key virulence metabolites involving all levels of QS were also decreased on exposure to auranofin. Surprisingly, iTRAQ analysis of the P. …
-
Auranofin Targets Thioredoxin Reductases in Trichomonas vaginalis
… trichomoniasis. Previous research has shown that auranofin, an FDA-approved drug, was effective at inhibiting activity of one of Trichomonas vaginalis’ isoforms of thioredoxin reductase (of which the organism has five total). Our research showed that only two of the isoforms were transcribed and …
-
Studies on auranofin and aurothioglucose in rheumatoid arthritis
Contains fulltext : mmubn000001_027420043.pdf (Publisher’s version ) (Open Access)
-
Decontamination of metals from firefighter turnout gear and solubility determination of auranofin.
… medium. Chapter THREE reports the solubility of auranofin, a well characterized drug, in water and cell medium. Chapter FIVE reports the solubility of synthesized gold(I) complexes in cell medium.
-
Identification and chemogenetic profiling of two antimicrobial auranofin analogs in B. cenocepacia K56-2
… drugs for a new use. One such example of this auranofin, which has antimicrobial activity against Gram-positive bacteria, with low to no activity against Gram-negatives. Thus, to create novel antimicrobials for Gram-negatives, specifically Burkholderia cenocepacia, we synthesized chemical …
-
Biochemical analysis of a potential drug target in the human protozoal pathogen Trichomonas vaginalis
… test its activity against known TrxR inhibitor, auranofin, using DTNB assay. Cell lysates of metronidazole susceptible and metronidazole resistant lines were also tested to see its activity against auranofin. Auranofin derivatives that were effective on E. histolytica recombinant TrxR were also …
-
Old drugs in a new light : investigating the gold Rheumatoid Arthritis medications as novel inhibitors of neuroinflammation
… including aurothiomalate, aurothioglucose, and auranofin, comprise another class of medications effective at reducing peripheral inflammation in rheumatoid arthritis patients. Their effects on neuroinflammation are unknown. In this thesis I demonstrate that 0.1 – 5 µM auranofin, but not the …
-
DRUG REPURPOSING FOR THE TREATMENT OF ACUTE MYELOID LEUKAEMIA WITH ADVERSE PROGNOSIS
… molecules in advanced phases of clinical trials. Auranofin, an antirheumatic drug, and pyrvinium pamoate, an anthelmintic agent, were identified and chosen from the list of 290 hits for in vitro and in vivo validation. We confirmed that in vitro treatment with auranofin and pyrvinium pamoate …
-
Repurposing non-antimicrobial drugs to treat multi-drug resistant bacterial and fungal infections
… present study identified four approved drugs (auranofin, ebselen, simvastatin and celecoxib) that exhibited potent antimicrobial activity against multidrug-resistant bacterial and fungal pathogens. Notably, auranofin, an FDA-approved anti-rheumatic drug possessed excellent antibacterial …
-
Targeting The Redox System to Overcome Mechanisms of Drug Resistance In Chronic Lymphocytic Leukemia
… 2 (EZH2) in drug resistance, and whether use of Auranofin has any therapeutic potential in CLL. This study determined that TCL1/p53-/- had elevated expression of transcription factors which regulate mitochondria biogenesis and increase in mitochondria DNA copy number. Second, TCL1/p53-/- mice had …
-
The role of TvTrxR in drug resistance and characterization of TvRad51 in homologous recombination in Trichomonas vaginalis
… drug screens have identified the compound, auranofin, as an effective agent against similar protozoans. The mechanism of inhibition by auranofin has been found to proceed through inhibition of the thioredoxin-based anti-oxidant pathway, targeting the enzyme thioredoxin reductase (TrxR). In …
-
Development of nanotherapeutics for the treatment of recalcitrant and antibiotic resistant infections
… activity of the anti-rheumatoid drug auranofin on N. fowleri. In vitro assays found that auranofin has an IC50 of 0.788 µg/mL with the HB-1 strain of N. fowleri. When these amoeba were treated with 3.0 µg/mL auranofin, staining of the nucleus with the cell membrane impermeable dye …
-
Mathematical models for immunodeficiency virus : post-treatment and memory activation
… and Darunavir, and H-iART was enforced with Auranofin. The drug Maraviroc (MRV) was proved to be a good CCR5 inhibitor, which is a HIV correceptor. The drug Auranofin has been shown to accelerate the activation rate of latent cells and also alters the kinetics of viral rebound when drug …
-
Bacterial Selenoproteins: A Role In Pathogenesis And Targets For Antimicrobial Development
… a stable complex formed upon reaction of auranofin (a gold containing drug) with selenide in vitro. Auranofin potently inhibits the growth of C. difficile but does not similarly affect other clostridia that do not utilize selenoproteins to obtain energy. Moreover, auranofin inhibits the …
-
Human enzyme depletion of cyst(e)ine for pancreatic cancer therapy
… and high translational potential provided by auranofin, a thioredoxin reductase inhibitor and an approved drug for rheumatoid arthritis. Treatment of cyst(e)inase and auranofin in combination caused a synergistic increase in mitochondrial ROS and apoptosis, and also led to inhibition of …
-
Synthesis, characterization, and anticancer evaluation of novel gold(I) phosphine thiolate complexes : solubility, cellular uptake, and cytotoxicity.
… anticancer agents. Inspired by the activity of auranofin and the limitations of existing platinum-based drugs such as cisplatin, this research sought to explore the therapeutic potential of systematically varied gold(I) complexes. Ten complexes, comprising two series with either …
-
Metabolic Manipulation of Glutathione as an Anticancer Therapeutic Target
… for anticancer effects in established tumours. Auranofin is a putative inhibitor of the thioredoxin system. HCT 116 p53-/- cells were resistant to auranofin at doses that HCT 116 p53+/+ cells were sensitive to, however concurrent exposure of auranofin and glutathione depletion through serine and …
-
Translational Frontiers for Chikungunya Virus: New World Epidemic, New Strains, New Therapeutic Targets
… and 16F16, as well as inhibitors EN460 and auranofin to PDI regulatory proteins endoplasmic reticulum oxidoreductin-1 (ERO-1) and thioredoxin reductase (TRX-R), respectively, all greatly reduced CHIKV replication in vitro; 16F16 likely caused misfolding of the envelope proteins and …
-
Novel therapies for high-risk leukaemia in children
… compounds identified two FDA-approved drugs, auranofin and disulfiram, which revealed a common ROS-mediated mechanism in potently inhibiting the viability of high-risk leukaemia cell lines and PDX in vitro. Preclinical testing of drug combinations revealed the potential of combined treatment …
-
The Effects Of Trivalent Arsenicals And Thioredoxin Reductase Inhibitors On Selenium Metabolism In Lung Cell Culture Models
… incorporation of selenium into selenoproteins. Auranofin, a gold chemotherapeutic inhibitor of TrxR1, also inhibited selenoprotein synthesis. These results seem to support the hypothesis that TrxR1 is needed for selenoprotein synthesis. However, siRNA mediated reduction of TrxR1 did not block …
Page 1 of 2